Patents
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
05/2013
05/29/2013CN101970429B 2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace)
05/28/2013US8450486 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
05/28/2013US8450304 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of CCR2
05/28/2013CA2560776C Vegetable based dioxanone derivatives, synthesis and uses thereof
05/23/2013WO2013073874A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same
05/23/2013WO2013073859A1 Novel organic electroluminescence compounds and organic electroluminescence device comprising the same
05/23/2013WO2013042138A3 Process for preparation of triazole antifungal drug, its intermediates and polymorphs thereof
05/23/2013US20130131351 Gpr120 receptor agonists and uses thereof
05/23/2013US20130131157 Treating various disorders using trkb agonists
05/23/2013US20130131084 Use of derivatives of indoles for the treatment of cancer
05/22/2013EP2594565A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594564A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594563A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013EP2594562A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors
05/22/2013CN103113359A Silibinin diunsymsuccinate and pharmaceutical salt thereof
05/22/2013CN102285945B Method for preparing alpha-carbonyl epoxy compound
05/22/2013CN102127030B 4-(substituted-1,3-dialkynyl)-4-(trifluoromethyl)benzo-1,4-dihydroxazole-2-one compounds and preparation method and applications thereof
05/22/2013CN101479250B Tetrazole-substituted arylamides
05/22/2013CN101316823B 2,4,5-triphenyl imidazoline derivatives as inhibitors of interaction between p53 and MDM2 proteins for use as anticancer agents
05/16/2013WO2013068461A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an o-containing group as vanilloid receptor ligands
05/16/2013US20130123521 Process for preparing divinylarene dioxides
05/16/2013US20130123519 Compounds useful in the synthesis of halichondrin b analogs
05/16/2013US20130119359 Organic Electroluminescent Element, Material for Organic Electroluminescent Element, and Light Emitting Device, Display Device and Illumination Device Each Using the Element
05/16/2013CA2854932A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an o-containing group as vanilloid receptor ligands
05/15/2013EP2592070A2 Tetrazole-substituted arylamides
05/15/2013EP2590968A1 Cyclic ether compounds useful as kinase inhibitors
05/15/2013CN103102347A Separation and purification method for peperomin B
05/15/2013CN101830892B Method for separating glycoside chemical components from tibetan capillaris
05/15/2013CN101808994B Compounds and methods for kinase modulation, and indications therefor
05/14/2013US8440608 Beta-substituted tetrandropyrana (on) s and method for the synthesis and the use thereof
05/14/2013CA2546657C 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/10/2013WO2013028045A3 Epoxy compound having alkoxysilyl group, method for preparing same, composition and cured material comprising same, and usage thereof
05/08/2013CN103087038A Liquid crystal compound containing benzo-1, 3-dioxolane and difluoro-methylenedioxy bridge
05/08/2013CN101631778B Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
05/07/2013CA2575073C Fungicidal composition containing acid amide derivative
05/02/2013WO2013061081A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
05/02/2013WO2013061074A1 Quinolines as fgfr kinase modulators
05/02/2013WO2013061005A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/02/2013WO2013061004A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013WO2013061002A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013WO2013060098A1 Kinase inhibitor and method for treatment of related diseases
05/02/2013US20130109639 Neprilysin inhibitors
05/02/2013CA2853440A1 Kinase inhibitor and method for treatment of related diseases
05/02/2013CA2853401A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
05/02/2013CA2853366A1 Quinolines as fgfr kinase modulators
05/02/2013CA2852404A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013CA2849977A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/02/2013CA2848263A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/01/2013EP2586778A2 Pyridazinone derivatives useful as glucan synthase inhibitors
05/01/2013CN103080106A Cyclic ether compounds useful as kinase inhibitors
04/2013
04/30/2013US8431250 Aromatic amine derivative, and organic electroluminescent element comprising the same
04/30/2013US8431245 Deuterated compounds for luminescent applications
04/25/2013US20130099208 Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound
04/24/2013EP2583956A2 A method of preparation of polycyclic, fused aromatic and heteroaromatic hydrocarbons and intermediates
04/24/2013EP2582674A1 Gpr120 receptor agonists and uses thereof
04/24/2013CN103059008A Method for preparing high-purity puerarin and daidzein at the same time
04/24/2013CN103059007A Erigeron breviscapus ketone A as well as preparation method and pharmaceutical composition and medical application thereof
04/24/2013CN103058987A Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound
04/24/2013CN103058968A Liquid crystal compound containing benzoxazole and difluoromethylenedioxy bridged linkage and preparation method and application thereof
04/24/2013CN102146062B Thiazolidine neuraminidase inhibitor and application thereof
04/24/2013CN101952270B Process for preparing nebivolol
04/23/2013US8426616 Triptolide lactone ring derivatives as immunomodulators and anticancer agents
04/23/2013US8426607 Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture
04/18/2013WO2013053422A1 Benzodioxepin-3-one compounds as dyes or as fluorescent emitters
04/18/2013US20130096128 Pyrazole compounds useful as protein kinase inhibitors
04/17/2013EP2581366A1 Renin Inhibitors
04/17/2013CN103052634A Theanine derivative, preparation method thereof, and use thereof for alleviating acne
04/17/2013CN103044461A Preparation method of tert-butyllithium solution
04/17/2013CN103044410A Production process for extracting isoorientin from bamboo product waste
04/17/2013CN103044409A Puerarin derivative or pharmaceutically acceptable salt and application thereof
04/16/2013US8420837 Method of preparing a nanoparticulate iron—crown ether complex
04/16/2013US8420673 Fungicidal amides
04/16/2013US8420628 Substituted beta-lactams
04/11/2013WO2013052157A1 Crystalline forms of afatinib di-maleate
04/11/2013WO2013050325A1 New strigolactone analogues and the use thereof for the treatment of plants
04/11/2013US20130090378 Process for extracting compound from cranberry leaves and related products
04/11/2013US20130090330 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
04/11/2013CA2842881A1 Cysteinyl leukotriene antagonists
04/10/2013EP2578569A1 Heterocyclic ring compound and h1 receptor antagonist
04/10/2013EP2576638A2 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof
04/10/2013EP2576514A1 Substituted isoquinolines and their use as tubulin polymerization inhibitors
04/10/2013EP2576510A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
04/10/2013CN103030617A Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
04/10/2013CN101058558B 4-Oxy-1(4H)-quinoline carboxylic acids compound and composition with aldose reductase inhibition activity and preparation method thereof
04/09/2013US8415489 Synthesis of polycyclic procyanidins
04/09/2013US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents
04/09/2013US8415121 Process for the manufacture of laidlomycin
04/09/2013CA2704986C Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
04/09/2013CA2555453C Cross-coupling process for production of aromatic compounds from aliphatic organic compounds and aromatic organometallic reagents
04/04/2013WO2013049565A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
04/04/2013WO2013047904A1 Amide compound and use thereof for controlling harmful arthropods
04/04/2013WO2013045028A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist
04/04/2013WO2012162115A3 Process for the preparation of compounds useful as inhibitors of sglt-2
04/04/2013US20130085068 Germination-stimulant carbamate derivatives and process for preparation thereof
04/04/2013US20130084330 Composition for the treatment of arthritis containing a dibenzo-p-dioxin derivative as the active ingredient
04/04/2013DE4432732B4 3-Aryl-benzofuranone als Stabilisatoren 3-aryl-benzofuranones as stabilizers
04/04/2013CA2850508A1 Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
04/04/2013CA2849820A1 Benzyl piperidine compounds as lysophosphatidic acid (lpa) receptor antagonist
04/03/2013CN103012384A Method for extracting silymarin from silybum marianum
04/03/2013CN102127042B Homoisoflavonoid compounds and preparation method and use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 120